Grantham, Mayo, Van Otterloo & Co (GMO)
ISRG icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Intuitive Surgical ISRG Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ISRG Stock Details ISRG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$567M Buy
1,230,930
+45,020
+4% +$22.8M 1.45% 25
2025
Q4 		$672M Buy
1,185,910
+46,251
+4% +$24.6M 1.72% 21
2025
Q3 		$510M Buy
1,139,659
+50,378
+5% +$24.2M 1.44% 25
2025
Q2 		$592M Buy
1,089,281
+15,541
+1% +$8.13M 1.78% 21
2025
Q1 		$532M Buy
1,073,740
+10,270
+1% +$5.68M 1.68% 22
2024
Q4 		$555M Sell
1,063,470
-433,844
-29% -$226M 1.81% 21
2024
Q3 		$736M Buy
1,497,314
+72,997
+5% +$34M 2.31% 14
2024
Q2 		$634M Buy
1,424,317
+58,167
+4% +$23.2M 2.14% 14
2024
Q1 		$545M Buy
1,366,150
+229,618
+20% +$86.8M 1.98% 17
2023
Q4 		$383M Buy
1,136,532
+232,392
+26% +$69.3M 1.69% 19
2023
Q3 		$264M Buy
904,140
+17,553
+2% +$5.48M 1.25% 24
2023
Q2 		$303M Buy
886,587
+284,564
+47% +$86.1M 1.4% 20
2023
Q1 		$154M Buy
602,023
+15,787
+3% +$3.89M 0.78% 33
2022
Q4 		$156M Sell
586,236
-19,480
-3% -$4.75M 0.83% 34
2022
Q3 		$114M Buy
605,716
+2,100
+0.3% +$451K 0.66% 38
2022
Q2 		$121M Buy
+603,616
New +$142M 0.66% 36
2017
Q2 		– Sell
-285,624
Closed -$24.3M – 609
2017
Q1 		$24.3M Sell
285,624
-193,473
-40% -$15.3M 0.14% 122
2016
Q4 		$33.8M Sell
479,097
-143,379
-23% -$10.5M 0.18% 118
2016
Q3 		$50.1M Sell
622,476
-198,261
-24% -$15.2M 0.24% 108
2016
Q2 		$60.3M Buy
820,737
+140,355
+21% +$9.88M 0.25% 92
2016
Q1 		$45.4M Sell
680,382
-20,529
-3% -$1.27M 0.17% 123
2015
Q4 		$42.5M Sell
700,911
-71,388
-9% -$4.01M 0.15% 115
2015
Q3 		$39.4M Sell
772,299
-433,386
-36% -$24.5M 0.14% 120
2015
Q2 		$64.9M Sell
1,205,685
-197,514
-14% -$11M 0.21% 86
2015
Q1 		$78.7M Sell
1,403,199
-47,070
-3% -$2.66M 0.24% 73
2014
Q4 		$85.2M Sell
1,450,269
-86,418
-6% -$4.81M 0.23% 75
2014
Q3 		$78.9M Buy
1,536,687
+933,633
+155% +$46.4M 0.21% 81
2014
Q2 		$27.6M Buy
603,054
+132,066
+28% +$5.83M 0.07% 124
2014
Q1 		$22.9M Buy
470,988
+182,349
+63% +$8.59M 0.06% 136
2013
Q4 		$12.3M Sell
288,639
-24,462
-8% -$1.03M 0.03% 193
2013
Q3 		$13.1M Sell
313,101
-57,114
-15% -$2.52M 0.03% 181
2013
Q2 		$20.8M Buy
+370,215
New +$20.4M 0.05% 132

Other funds holding ISRG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ISRG Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Intuitive Surgical (ISRG) stake by 3.8% in Q1 2026, buying an estimated $22.8M and bringing the position to 1,230,930 shares worth $567M. The position accounts for 1.45% of the portfolio, ranked #25.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ISRG in Q2 2013 and has held it in 32 quarters since. The position peaked at $736M in Q3 2024. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 1,230,930 shares of Intuitive Surgical worth $567M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 45,020 Intuitive Surgical shares in Q1 2026, an estimated $22.8M.
  • Intuitive Surgical made up 1.45% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #25 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Intuitive Surgical in Q2 2013 and has held it in 32 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Intuitive Surgical position peaked at $736M in Q3 2024.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.